Skip to main content
. 2021 Jul 26;17(10):3735–3746. doi: 10.1080/21645515.2021.1932216

Figure 2.

Figure 2.

HZ cases avoided with RZV vaccination per one million people over the respective age cohorts’ lifetime, compared with no vaccination, in the mass vaccination setting (base case). HZ: herpes zoster; RZV: recombinant zoster vaccine; YOA: years of age. Step increases over time (particularly pronounced in the 50–59 YOA cohort) are due to incidence being included as an age-specific step function